Bill Amendment: AZ HB2491 | 2014 | Fifty-first Legislature 2nd Regular
Bill Title: Newborn screening program
Status: 2014-04-23 - Chapter 171 [HB2491 Detail]
Download: Arizona-2014-HB2491-SENATE_ADOPTED_AMENDMENT_Barto_flr_amend_ref_Bill_adopted.html
Bill
Number: H.B. 2491
Barto Floor Amendment
Reference to: House engrossed bill
Amendment drafted by: Marianne Yamnik
FLOOR AMENDMENT EXPLANATION
Establishes an advisory committee within the Department of Health Services to study the financing and availability of vaccines for newborns, children and adolescents.
Requires the committee to develop recommendations as outlined and report findings to the Governor and Legislature by December 15, 2014.
Fifty-first Legislature Barto
Second Regular Session H.B. 2491
BARTO FLOOR AMENDMENT
SENATE AMENDMENTS TO H.B. 2491
(Reference to House engrossed bill)
“Sec. 3. Department of health services; vaccine financing and availability advisory committee; report
A. The department of health services shall establish a vaccine financing and availability advisory committee to study the financing and availability of vaccines for newborns, children and adolescents.
B. The director of the department of health services shall serve as chairperson of the committee and shall appoint the following members:
1. Two members who are representatives of different health care insurers that are licensed pursuant to title 20, Arizona Revised Statutes, and that offer products in the commercial market that include coverage for newborn, childhood and adolescent vaccines.
2. Three health professionals who are licensed pursuant to title 32, Arizona Revised Statutes, whose current practice includes administering newborn or childhood and adolescent vaccines as follows:
(a) A physician who is licensed pursuant to title 32, chapter 13 or 17, Arizona Revised Statutes and who specializes in pediatrics.
(b) A physician who is licensed pursuant to title 32, chapter 13 or 17, Arizona Revised Statutes and who specializes in family medicine.
(c) A nurse practitioner who is licensed and certified pursuant to title 32, chapter 15, Arizona Revised Statutes.
3. Two directors of local health departments one of whom shall be from a county having a population of at least three million persons.
4. One member who is a representative of an Arizona nonprofit statewide coalition whose mission is to foster a comprehensive, sustained community program for the immunization of residents of this state against vaccine-preventable diseases.
5. One member who is a representative of a vaccine manufacturer or a national association of vaccine manufacturers and who has experience in vaccine policy.
6. One member who is a representative of a statewide association of pharmacists.
7. One member who is a representative of an Arizona company that is not a health care insurer or a self-insured employer and that offers its employees a health insurance product in the commercial market that includes coverage for newborn, childhood and adolescent vaccines.
C. The directors of the Arizona health care cost containment system administration and the department of insurance, or their designees, shall serve as nonvoting members of the committee.
D. Committee members are not eligible to receive compensation or reimbursement of expenses.
E. The Committee shall develop recommendations regarding the following and submit a written report of its findings on or before December 15, 2014, to the governor, the president of the senate and the speaker of the house of representatives and shall provide a copy of this report to the secretary of state:
1. The existing system of the financing, storage, distribution and availability of newborn, childhood and adolescent vaccine products and the potential impacts on the health care system, taxpayers and the community at large.
2. The costs associated with, and the adequacy of reimbursement levels for newborn, childhood and adolescent vaccines administered by private and public providers in all counties in this state.
3. The vaccine financing, storage, distribution and reimbursement models utilized in other states.
F. To the extent possible, the committee shall include and consider any estimated costs or cost savings to state and local governments associated with the committee's recommendations.
G. The committee may:
1. Request information, data and reports from any state agency, political subdivision or other persons or businesses involved in the public or private financing or administration of newborn, childhood or adolescent vaccines.
2. Hold hearings and take testimony from affected persons, including members of the public.
H. The committee shall maintain documents in a manner that preserves the confidentiality of confidential business information that may be disclosed to the committee during the course of its business.
I. This section is repealed from and after December 31, 2015.”
Amend title to conform
